Pigio™ ICU: Gaze-to-Speech
source

Pigio™ ICU: Gaze-to-Speech

(1)
Price
Free
Category
Medical
Last update
Jul 13, 2021
Publisher
Innodem Neurosciences Contact publisher
View in store
Loading...

Ratings & Reviews performance

Ratings & Reviews performance provides an overview of what users think of your app. Here are the key metrics to help you identify how your app is rated by users and how successful is your review management strategy.

Number of reviews,
total
1
Avg rating,
total
⭐1.0
Loading...

User Reviews for Pigio™ ICU: Gaze-to-Speech

Why to reply to reviews?face_screaming

User reviews affect conversion to installs and app rating. Featured and helpful reviews are the first to be noticed by users and in case of no response can affect download rate.

Description

1008 chars

Pigio™ allows you to control its mobile interface using your eyes. The Pigio™ ICU app will turn your iPad into an intuitive communication tool. Through the combination of Apple’s text to speech and our innovative eye movement tracking technology, Pigio™ ICU enables users to gaze at icons triggering a Gaze-to-Speech™ engine. No hand movements are required. If you are a healthcare professional or caregiver and want to improve communication for people without a voice, you can consider Pigio™ the new standard of digital accessibility. All the basic functionality is FREE. In the premium version, available through an In-App purchase, a yearly subscription will unlock more menus and functions providing more personalized options. Contrary to infrared eye-tracking solutions, Pigio™ ICU works even if the user is wearing glasses. Multilingual (English, French, Spanish). End user licence agreement: https://innodemneurosciences.com/eula Privacy Policy: https://innodemneurosciences.com/privacy-policy

Screenshots

https://is4-ssl.mzstatic.com/image/thumb/PurpleSource124/v4/6e/a4/80/6ea48073-2fd4-f780-50f8-d71de15f2ae2/09888000-42bc-40ef-8df3-7c09383dac69_Screenshots_En-1.png/2048x2732bb.pnghttps://is2-ssl.mzstatic.com/image/thumb/PurpleSource114/v4/92/95/f5/9295f543-34d9-c6d5-b35a-977f8d7195bf/eb960fa1-c30e-49f3-bf3e-46c1cfa17a18_Screenshots_En-2.png/2048x2732bb.pnghttps://is5-ssl.mzstatic.com/image/thumb/PurpleSource124/v4/75/ac/7c/75ac7cc0-95dd-00b8-748e-40c1254d2431/6dd5dd5f-91d2-4c8f-9277-43549b3738df_Screenshots_En-3.png/2048x2732bb.pnghttps://is3-ssl.mzstatic.com/image/thumb/PurpleSource124/v4/fc/1c/6b/fc1c6b23-cd89-8751-3da4-5a6d6eb145d6/c1c5a58a-f4c7-4f6f-b428-a046f6338da2_Screenshots_En-4.png/2048x2732bb.pnghttps://is4-ssl.mzstatic.com/image/thumb/PurpleSource114/v4/95/6e/68/956e68cd-bd20-ceda-0823-29b8be3bada2/8d87f145-f846-4705-b8a6-c2d662791722_Screenshots_En-5.png/2048x2732bb.png
Loading...
Loading...

Find growth insights on our blog

React to user feedback and market trends faster